Ligand validation:7ZZU

NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID

NHE is a Ligand Of Interest in 7ZZU designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7ZZU_NHE_A_614	45%	71%	0.161	0.891	0.56	0.55	-	-	1	0	100%	0.7
7ZZP_NHE_B_614	93%	74%	0.079	0.973	0.54	0.46	-	-	0	0	100%	0.77
7ZZT_NHE_B_604	64%	68%	0.107	0.906	0.54	0.69	-	-	0	0	100%	0.67
7ZZR_NHE_B_604	49%	68%	0.166	0.914	0.54	0.7	-	-	0	0	100%	0.67
8A0B_NHE_B_604	37%	58%	0.165	0.861	0.57	1.04	-	1	5	0	100%	0.67
5TSP_NHE_A_1001	99%	51%	0.053	0.99	0.93	0.98	-	1	0	0	100%	1
3WXP_NHE_A_404	99%	10%	0.052	0.986	1.81	2.52	4	7	0	0	100%	0.94
2DSY_NHE_C_1001	99%	34%	0.051	0.979	1.49	1.14	1	1	0	0	100%	1
3WH6_NHE_A_505	99%	13%	0.056	0.984	1.25	2.71	2	5	0	0	100%	1
8WNA_NHE_A_502	98%	70%	0.059	0.983	0.38	0.78	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.